Zepp Health Corporation
ZEPP
$2.56
$0.000.00%
NYSE
| 03/31/2024 | 12/31/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -51.83% | -0.09% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -51.83% | -0.09% | |||
| Cost of Revenue | -53.35% | -1.36% | |||
| Gross Profit | -48.98% | 2.40% | |||
| SG&A Expenses | 0.81% | 4.02% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -32.15% | 0.84% | |||
| Operating Income | -2,243.72% | -50.63% | |||
| Income Before Tax | -1,002.70% | 261.11% | |||
| Income Tax Expenses | -97.42% | 4,132.93% | |||
| Earnings from Continuing Operations | -1,177.69% | -400.16% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 317.57% | -155.64% | |||
| Net Income | -1,158.74% | -384.32% | |||
| EBIT | -2,243.72% | -50.63% | |||
| EBITDA | -631.40% | -25.45% | |||
| EPS Basic | -1,070.80% | -386.67% | |||
| Normalized Basic EPS | -718.64% | 344.87% | |||
| EPS Diluted | -1,080.49% | -450.23% | |||
| Normalized Diluted EPS | -718.64% | 368.92% | |||
| Average Basic Shares Outstanding | 7.45% | -0.67% | |||
| Average Diluted Shares Outstanding | 7.45% | -5.71% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||